Envestnet Asset Management
IMCR icon

Envestnet Asset Management’s Immunocore IMCR Stock Holding History

Envestnet Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-56,825
Closed -$1.71M – 4890
2026
Q1 		$1.71M Buy
56,825
+1,635
+3% +$52.9K ﹤0.01% 3116
2025
Q4 		$1.92M Sell
55,190
-5,245
-9% -$185K ﹤0.01% 2860
2025
Q3 		$2.2M Sell
60,435
-2,852
-5% -$96.9K ﹤0.01% 2818
2025
Q2 		$1.99M Sell
63,287
-3,972
-6% -$123K ﹤0.01% 2828
2025
Q1 		$2M Buy
67,259
+735
+1% +$22K ﹤0.01% 2729
2024
Q4 		$1.96M Sell
66,524
-6,456
-9% -$204K ﹤0.01% 2692
2024
Q3 		$2.27M Buy
72,980
+2,409
+3% +$87.6K ﹤0.01% 2566
2024
Q2 		$2.39M Buy
70,571
+606
+0.9% +$30.9K ﹤0.01% 2482
2024
Q1 		$4.55M Buy
69,965
+1,391
+2% +$95.5K ﹤0.01% 2046
2023
Q4 		$4.68M Buy
68,574
+14,305
+26% +$744K ﹤0.01% 1942
2023
Q3 		$2.82M Buy
54,269
+35,876
+195% +$2.12M ﹤0.01% 2169
2023
Q2 		$1.1M Buy
18,393
+13,371
+266% +$763K ﹤0.01% 2683
2023
Q1 		$248K Sell
5,022
-103
-2% -$5.79K ﹤0.01% 3543
2022
Q4 		$292K Buy
+5,125
New +$288K ﹤0.01% 3439

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Envestnet Asset Management's IMCR Position: Q2 2026 in Review

Envestnet Asset Management sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 56,825 shares — an estimated $1.71M sold.

Envestnet Asset Management first reported a position in IMCR in Q4 2022 and held it in 14 quarters. The position peaked at $4.68M in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Envestnet Asset Management reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 56,825 Immunocore shares in Q2 2026, an estimated $1.71M.
  • Envestnet Asset Management first reported a position in Immunocore in Q4 2022 and held it in 14 quarters.
  • Envestnet Asset Management's Immunocore position peaked at $4.68M in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.